Results 171 to 180 of about 2,105 (188)

Marimastat promising in advanced cancers

Inpharma Weekly, 1996
openaire   +1 more source

Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma

International Journal of Radiation Oncology Biology Physics, 2002
Penny Sneed, Kathleen R Lamborn, Sandeep Kunwar   +2 more
exaly  

Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake, Crotalus atrox

Toxins, 2020
Divyashree Ravishankar, Amita Mehmi, Steven Trim   +2 more
exaly  

Is British Biotech's Marimastat a major cancer drug?

Nature Biotechnology, 1996
openaire   +1 more source

Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA

British Journal of Cancer, 1999
S A Watson
exaly  

USE OF MARIMASTAT FOR PREVENTING AND/OR TREATING EPILEPTOGENESIS

2020
KACZMAREK LESZEK, PIJET-BINKIEWICZ BARBARA, KONOPKA ANNA, REJMAK-KOZICKA EMILIA   +3 more
openaire   +3 more sources

Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation★

Journal of Neuro-Oncology, 2006
Gregory Fuller, Víctor A Levin, W K Alfred Yung   +2 more
exaly  

Reduced angiogenesis by marimastat in peritoneal dissemination model of gastric cancer

Gastroenterology, 2000
Norihito Wada, Yoshihide Otani, Tetsuro Kubota, Masaru Kimata, Akiko Minagawa, Koichiro Kumai, Kaori Kameyama, Yasunori Okada, Masaki Kitajima   +8 more
openaire   +1 more source

DIFFERENTIAL EFFECTS BETWEEN MARIMASTAT, A TNF-α CONVERTING ENZYME INHIBITOR, AND ANTI-TNF-α ANTIBODY ON MURINE MODELS FOR SEPSIS AND ARTHRITIS

Cytokine, 2002
Fumio Tsuji, Shiro Mita, Kenji Oki
exaly  

Marimastat randomised trial for advanced pancreatic cancer announced

The Lancet, 1996
openaire   +1 more source